Literature DB >> 23709750

The NOMS framework: approach to the treatment of spinal metastatic tumors.

Ilya Laufer1, David G Rubin, Eric Lis, Brett W Cox, Michael D Stubblefield, Yoshiya Yamada, Mark H Bilsky.   

Abstract

BACKGROUND: Spinal metastases frequently arise in patients with cancer. Modern oncology provides numerous treatment options that include effective systemic, radiation, and surgical options. We delineate and provide the evidence for the neurologic, oncologic, mechanical, and systemic (NOMS) decision framework, which is used at Memorial Sloan-Kettering Cancer Center to determine the optimal therapy for patients with spine metastases.
METHODS: We provide a literature review of the integral publications that serve as the basis for the NOMS framework and report the results of systematic implementation of the NOMS-guided treatment.
RESULTS: The NOMS decision framework consists of the neurologic, oncologic, mechanical, and systemic considerations and incorporates the use of conventional external beam radiation, spinal stereotactic radiosurgery, and minimally invasive and open surgical interventions. Review of radiation oncology and surgical literature that examine the outcomes of treatment of spinal metastatic tumors provides support for the NOMS decision framework. Application of the NOMS paradigm integrates multimodality therapy to optimize local tumor control, pain relief, and restoration or preservation of neurologic function and minimizes morbidity in this often systemically ill patient population.
CONCLUSION: NOMS paradigm provides a decision framework that incorporates sentinel decision points in the treatment of spinal metastases. Consideration of the tumor sensitivity to radiation in conjunction with the extent of epidural extension allows determination of the optimal radiation treatment and the need for surgical decompression. Mechanical stability of the spine and the systemic disease considerations further help determine the need and the feasibility of surgical intervention.

Entities:  

Mesh:

Year:  2013        PMID: 23709750      PMCID: PMC4063402          DOI: 10.1634/theoncologist.2012-0293

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  46 in total

1.  Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis.

Authors:  Samuel Ryu; Fang Fang Yin; Jack Rock; Jingeng Zhu; Archie Chu; Eduard Kagan; Lisa Rogers; Munther Ajlouni; Mark Rosenblum; Jae Ho Kim
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

2.  Short-course radiotherapy (8 Gy x 2) in metastatic spinal cord compression: an effective and feasible treatment.

Authors:  E Maranzano; P Latini; E Perrucci; S Beneventi; M Lupattelli; E Corgna
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-07-15       Impact factor: 7.038

3.  Reliability analysis of the epidural spinal cord compression scale.

Authors:  Mark H Bilsky; Ilya Laufer; Daryl R Fourney; Michael Groff; Meic H Schmidt; Peter Paul Varga; Frank D Vrionis; Yoshiya Yamada; Peter C Gerszten; Timothy R Kuklo
Journal:  J Neurosurg Spine       Date:  2010-09

4.  Percutaneous vertebroplasty and kyphoplasty in patients with multiple myeloma.

Authors:  Benedetta Bartolozzi; Chiara Nozzoli; Cesare Pandolfo; Elisabetta Antonioli; Giancarlo Guizzardi; Riccardo Morichi; Alberto Bosi
Journal:  Eur J Haematol       Date:  2006-02       Impact factor: 2.997

5.  Indications for nonoperative treatment of spinal cord compression due to breast cancer.

Authors:  C A Cobb; M E Leavens; N Eckles
Journal:  J Neurosurg       Date:  1977-11       Impact factor: 5.115

6.  Vertebroplasty and kyphoplasty.

Authors:  Allen W Burton; Ehud Mendel
Journal:  Pain Physician       Date:  2003-07       Impact factor: 4.965

7.  Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression.

Authors:  F Bach; B H Larsen; K Rohde; S E Børgesen; F Gjerris; T Bøge-Rasmussen; N Agerlin; B Rasmusson; P Stjernholm; P S Sørensen
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 8.  Shifting paradigms in the treatment of metastatic spine disease.

Authors:  Mark H Bilsky; Ilya Laufer; Shane Burch
Journal:  Spine (Phila Pa 1976)       Date:  2009-10-15       Impact factor: 3.468

9.  Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases.

Authors:  Peter S Rose; Ilya Laufer; Patrick J Boland; Andrew Hanover; Mark H Bilsky; Josh Yamada; Eric Lis
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

Review 10.  Palliative radiotherapy trials for bone metastases: a systematic review.

Authors:  Edward Chow; Kristin Harris; Grace Fan; May Tsao; Wai M Sze
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

View more
  120 in total

1.  Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.

Authors:  K Liang Zeng; Arjun Sahgal; Zain A Husain; Sten Myrehaug; Chia-Lin Tseng; Jay Detsky; Arman Sarfehnia; Mark Ruschin; Mikki Campbell; Monica Foster; Sunit Das; Nir Lipsman; Georg A Bjarnason; Eshetu G Atenafu; Pejman Jabehdar Maralani; Hany Soliman
Journal:  J Neurooncol       Date:  2021-01-16       Impact factor: 4.130

2.  The C7 pedicle as a superior fixation point in spinal stabilization for spinal metastatic disease.

Authors:  Harjot Thind; Andrew J Fabiano
Journal:  J Spine Surg       Date:  2018-03

3.  Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy.

Authors:  Matthew M Gestaut; Nitika Thawani; Sangroh Kim; Veera R Gutti; Sameer Jhavar; Niloyjyoti Deb; Andrew Morrow; Russell A Ward; Jason H Huang; Mehul Patel
Journal:  J Neurooncol       Date:  2017-04-13       Impact factor: 4.130

4.  Patient-reported outcomes after surgical stabilization of spinal tumors: symptom-based validation of the Spinal Instability Neoplastic Score (SINS) and surgery.

Authors:  Ibrahim Hussain; Ori Barzilai; Anne S Reiner; Natalie DiStefano; Lily McLaughlin; Shahiba Ogilvie; Mark Bilsky; Ilya Laufer
Journal:  Spine J       Date:  2017-07-13       Impact factor: 4.166

Review 5.  [Prognosis scores for spinal metastases].

Authors:  N H von der Höh; J Gulow; S K Tschöke; A Völker; C E Heyde
Journal:  Orthopade       Date:  2013-09       Impact factor: 1.087

Review 6.  Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress.

Authors:  Paola Jimenez; Claudio Tatsui; Aaron Jessop; Sonali Thosani; Camilo Jimenez
Journal:  Curr Oncol Rep       Date:  2017-10-28       Impact factor: 5.075

Review 7.  Thermal Ablation of Bone Metastases.

Authors:  Michael R Moynagh; A Nicholas Kurup; Matthew R Callstrom
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

8.  The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.

Authors:  Yoshiya Yamada; Evangelia Katsoulakis; Ilya Laufer; Michael Lovelock; Ori Barzilai; Lily A McLaughlin; Zhigang Zhang; Adam M Schmitt; Daniel S Higginson; Eric Lis; Michael J Zelefsky; James Mechalakos; Mark H Bilsky
Journal:  Neurosurg Focus       Date:  2017-01       Impact factor: 4.047

Review 9.  Top Ten Tips Palliative Care Clinicians Should Know About Spinal Tumors.

Authors:  Theresa Williamson; Brice Painter; Elizabeth P Howell; C Rory Goodwin
Journal:  J Palliat Med       Date:  2018-12-20       Impact factor: 2.947

10.  Development and validation of a prognostic nomogram for the overall survival of patients living with spinal metastases.

Authors:  Xiong-Gang Yang; Jiang-Tao Feng; Feng Wang; Xin He; Hao Zhang; Li Yang; Hao-Ran Zhang; Yong-Cheng Hu
Journal:  J Neurooncol       Date:  2019-09-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.